1. Federal Food, Drug, and Cosmetic Act as Amended by the Food and Drug Administration Act of 1997, Chapter IX, Miscellaneous. Sec. 906, Practice of Medicine. Food and Drug Administration, Revised Nov. 17, 1998.
2. Cool DA. Draft guidance to NRC regions for licensing Cordis and Novoste intravascular brachytherapy systems. Division of Industrial and Medical Nuclear Safety, US Nuclear Regulatory Commission, February 2, 2001.
3. Cool DA. Revised guidance for licensing intravascular brachytherapy procedures. Division of Industrial and Medical Nuclear Safety, US Nuclear Regulatory Commission, June 12, 2001.
4. Hickey JW. Guidance to NRC regions for licensing Cordis, Novoste, and Guidant intravascular brachytherapy systems. Division of Industrial and Medical Nuclear Safety, US Nuclear Regulatory Commission, December 12, 2001.
5. Information required for licensing remote afterloading devices. Policy and Guidance Directive FC 86-4, Revision 1. Division of Industrial and Medical Nuclear Safety, US Nuclear Regulatory Commission, September 28, 1993.